Tag: chemotherapy
Articles
News
Foods
Studies
- 3, 3'-diindolylmethane enhances taxotere-induced growth inhibition of breast cancer cells through down-regulation of FoxM1
- 3,3' -diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells
- 5-Fluorouracil combined with apigenin enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells
- A comprehensive evaluation of outcomes for inflammatory breast cancer
- A prospective surveillance model for physical rehabilitation of women with breast cancer: Chemotherapy-induced peripheral neuropathy
- Addition of Bevacizumab to Conventional Therapy Improved Progression-Free Survival in HER2-Positive Breast Cancer
- Addition of Trastuzumab May Potentially Equalize Disease-Free Survival Outcomes Among Obese and Normal-Weight Patients
- Adjuvant bisphosphonates in breast cancer: Are we witnessing the emergence of a new therapeutic strategy?
- Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: a prospective randomized controlled multi-center trial
- Adjuvant Trastuzumab in HER2-Positive Breast Cancer
- Aged Garlic Extract Protects against Doxorubicin-Induced Cardiotoxicity In Rats
- Antiemetic effect of ginger in gynecologic oncology patients receiving cisplatin
- Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort
- Antioxidants Suppress Apoptosis
- Antitumor activity of doxorubicin is enhanced by curcumin
- ANZAC: A Randomised Neoadjuvant Biomarker Study Investigating the Anti-Tumour Activity of the Addition of Zoledronic Acid to Chemotherapy in Breast Cancer
- Apigenin augments the growth inhibitory effects of doxorubicin in breast cancer cells derived from African American patients
- Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- Astaxanthin as an adjunct therapy for breast cancer
- Attenuation of Cytotoxic Natural Product DNA Intercalating Agents by Caffeine
- Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancer
- Black-white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US
- BRCA2 deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure
- Breast cancer affects both the hippocampus volume and the episodic autobiographical memory retrieval
- Breast cancer in elderly women (at least 80 years): variation in standard of care?
- Breast Cancer Mortality Higher in Hispanic Women
- Breast cancer occurred after Hodgkin's disease: Clinico-pathological features, treatments and outcome: Analysis of 214 cases
- Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment
- Cadmium influences the 5-Fluorouracil cytotoxic effects on breast cancer cells
- Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer
- Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats
- Cardiotoxic Chemotherapy is Associated with Increased Heart Failure Risk Among Women with Breast Cancer in the Cancer Research Network
- Cell proliferation of feline and human breast cancer cell types is inhibited by pomegranate juice
- Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy
- Chemotherapy-induced amenorrhea: Predictive markers of response to neoadjuvant chemotherapy in breast cancer
- Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients’ quality of life
- Cisplatin combination with allyl isothiocyanate, a constituent of cruciferous vegetables, synergistically increases cancer cell death through activation of caspase 3 and downregulation of the antiapoptotic protein Bcl-2 and survivin
- Classical lobular breast carcinoma consistently lacks topoisomerase-IIα gene amplification: implications for the tailored use of anthracycline-based chemotherapies
- Clinical outcome of triple-negative primary breast cancer in older women: Comparison with their younger counterparts
- Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity
- Cognitive functioning after cancer treatment
- Comparison of locoregional recurrence in triple-negative and HER2-positive breast cancer subtype after breast-conserving therapy and modern systemic therapy
- Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
- Curcumin enhances the efficacy of chemotherapy by tailoring p65NFκB-p300 cross-talk in favor of p53-p300 in breast cancer
- Curcumin improves MMC-based chemotherapy by simultaneously sensitising cancer cells to MMC and reducing MMC-associated side-effects
- Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins
- Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model
- Curcumin Suppresses the Paclitaxel-Induced Nuclear Factor-[kappa]B in Breast Cancer Cells and Potentiates the Growth Inhibitory Effect of Paclitaxel in a Breast Cancer Nude Mice Model
- Cyclophosphamide Creates a Receptive Microenvironment for Prostate Cancer Skeletal Metastasis
- Decrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluation
- Delays in Adjuvant Chemotherapy Treatment Among Patients With Breast Cancer Are More Likely in African American and Hispanic Populations: A National Cohort Study 2004-2006
- Differences in long-term survival for Hispanic and non-Hispanic white women with breast cancer
- Differential modulation of cisplatin and doxorubicin efficacies in leukemia cells by flavonoids
- Docosahexaenoic acid increases doxorubicin’s cytotoxicity against breast cancer cell lines
- Does Cancer Protect Against Alzheimer Disease or Vice Versa?: New Data from a Large Population‐Based Study
- Doxorubicin and selenium cooperatively induce fas signaling in the absence of Fas/Fas ligand interaction
- Early identification of trastuzumab-related cardiotoxicity with speckle-tracking echocardiography
- Effect of ascorbic acid on reactive oxygen species production in chemotherapy and hyperthermia in prostate cancer cells
- Effect of Ginger on Acute and Delayed Chemotherapy-Induced Nausea and Vomiting: A Pilot, Randomized, Open-Label Clinical Trial
- Effect of low-protein diet on anthracycline pharmacokinetics and cardiotoxicity
- Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer
- Effect of Selected Phytochemicals and Apple Extracts on NF-κB Activation in Human Breast Cancer MCF-7 Cells
- Effects of doxorubicin on brain activity and resting-state functional connectivity in rats: fMRI studies
- Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells
- Effects of quercetin on the bioavailability of doxorubicin in rats: Role of CYP3A4 and P-gp inhibition by quercetin
- Effects of the olive, extra virgin olive and canola oils on cisplatin-induced clastogenesis in Wistar rats
- Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer
- Estrogen Receptor Positive Breast Cancer Identified by 95-Gene Classifier as at High Risk for Relapse Shows Better Response to Neoadjuvant Chemotherapy
- Evaluation of the Antiproliferative Effects of Essiac™ on In Vitro and In Vivo Models of Prostate Cancer Compared to Paclitaxel
- Fasting and differential chemotherapy protection in patients
- Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy
- Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients
- Fatigue and quality of life in breast cancer survivors: temporal courses and long-term pattern
- Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: a systematic review
- Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy
- Grape Seed and Skin Extract Protects Against Acute Chemotherapy Toxicity induced by Doxorubicin in Rat Heart
- Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study
- Hematologic toxicity with adjuvant docetaxel and cyclophosphamide in early breast cancer
- Hepatotoxicity in breast cancer patients post-chemotherapy with docetaxel, doxorubucin, and cyclophosphamide
- High Prevalence of Vitamin D Deficiency Despite Supplementation in Premenopausal Women With Breast Cancer Undergoing Adjuvant Chemotherapy
- High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death
- Hsp27 Protects Adenocarcinoma Cells from UV-Induced Apoptosis by Akt and p21-Dependent Pathways of Survival
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- Impact of Adjuvant Chemo- and Radiotherapy on the Cellular Immune System of Breast Cancer Patients
- Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials
- Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial
- In vitro and in vivo antitumor effect of 5-FU combined with piplartine and piperine
- Incidence and Prognostic Impact of Amenorrhea During Adjuvant Therapy in High-Risk Premenopausal Breast Cancer: Analysis of a National Cancer Institute of Canada Clinical Trials Group Study—NCIC CTG MA.5
- Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens
- Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice
- Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel
- Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy
- Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in Combination trial
- Influence of Garlic (Allium sativum) on the Pharmacokinetics of Docetaxel
- Interaction of celecoxib with different anti-cancer drugs is antagonistic in breast but not in other cancer cells
- Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro
- Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging
- Late pancreatic toxicity in patients with breast cancer after taxane-anthracycline-based neoadjuvant and adjuvant chemotherapy
- Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells
- Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy
- Long-Term Outcomes in Stage IIIB Breast Cancer Patients Who Achieved Less Than a Pathological Complete Response After Primary Chemotherapy
- Long-term toxic effects of adjuvant chemotherapy in breast cancer
- Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer
- Longitudinal Assessment of Chemotherapy-Induced Structural Changes in Cerebral White Matter and Its Correlation With Impaired Cognitive Functioning
- Longitudinal Assessment of Cognitive Changes Associated With Adjuvant Treatment for Breast Cancer: Impact of Age and Cognitive Reserve
- Luteolin as a glycolysis inhibitor offers superior efficacy and lesser toxicity of doxorubicin in breast cancer cells
- Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: involvement of cell line-specific apoptotic mechanisms
- Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype
- Management of Operable Invasive Breast Cancer in Women Over the Age of 70: Long-Term Results of a Large-Scale Single-Institution Experience
- Mesenchymal Stem Cells Induce Resistance to Chemotherapy through the Release of Platinum-Induced Fatty Acids
- Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- Metformin and the mTOR Inhibitor Everolimus (RAD001) Sensitize Breast Cancer Cells to the Cytotoxic Effect of Chemotherapeutic Drugs In Vitro
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- Methylseleninic Acid Enhances Paclitaxel Efficacy for the Treatment of Triple-Negative Breast Cancer
- Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer
- Modulation of multidrug resistance and apoptosis of cancer cells by selected carotenoids
- Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer
- Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer
- Muscle and Joint Symptoms in Breast Cancer Patients Receiving Taxane-Based Chemotherapy
- Neoadjuvant Chemotherapy Increases the Rate of Breast Conservation in Lobular-Type Breast Cancer Patients
- Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy
- New model system for testing effects of flavonoids on doxorubicin-related formation of hydroxyl radicals
- Oral Bisphosphonate Did Not Improve Prognosis for Patients With Breast Cancer
- Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer
- Patterns of Dementia Diagnosis in Surveillance, Epidemiology, and End Results Breast Cancer Survivors Who Use Chemotherapy
- Patterns of Local and Distant Disease Relapse in Patients with Breast Cancer Treated with Primary Chemotherapy: Do Patients with a Complete Pathological Response Differ from Those with Residual Tumour in the Breast?
- Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells
- Pre-treatment hormonal receptor status and Ki67 index predict pathologic complete response to neoadjuvant trastuzumab/taxanes but not disease-free survival in HER2-positive breast cancer patients
- Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score
- Predictive role of molecular subtypes in response to neoadjuvant chemotherapy in breast cancer patients in northeast china
- Predictors of Pathologic Complete Response After Standard Neoadjuvant Chemotherapy in Triple-negative Breast Carcinoma
- Predictors of timing of adjuvant chemotherapy in older women with hormone receptor-negative, stages II-III breast cancer
- Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer
- Prefrontal Cortex and Executive Function Impairments in Primary Breast Cancer
- Prevalence of breast cancer treatment sequelae over 6 years of follow-up: The Pulling Through Study
- Prognosis and Outcome of Small (1 cm), Node-Negative Breast Cancer on the Basis of Hormonal and HER-2 Status
- Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer
- Prognostic Significance of Neutropenia on Day One of Anthracycline-Based Neoadjuvant Chemotherapy in Operable Breast Cancer
- Prognostic value of chemotherapy-induced neutropenia in early-stage breast cancer
- Protective effect of saffron (Crocus sativus L.) aqueous extract against genetic damage induced by anti-tumor agents in mice
- Racial variation in breast cancer treatment among department of defense beneficiaries
- Reduced Levels of IGF-I Mediate Differential Protection of Normal and Cancer Cells in Response to Fasting and Improve Chemotherapeutic Index
- Relationship Between Chemotherapy Use and Cognitive Impairments in Older Women With Breast Cancer: Findings From a Large Population-Based Cohort
- Relationship between reproductive history, anthropometrics, lifestyle factors, and the likelihood of persistent chemotherapy-related amenorrhea in women with premenopausal breast cancer
- Response to influenza virus vaccination during chemotherapy in patients with breast cancer
- Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer: Results from the GeparQuattro study (GBG 40)
- Resumption or persistence of menstruation after cytotoxic chemotherapy is a prognostic factor for poor disease-free survival in premenopausal patients with early breast cancer
- Resveratrol chemosensitizes breast cancer cells to melphalan by cell cycle arrest
- Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro
- Risk Factors of Developing Long-Lasting Breast Pain After Breast Cancer Radiotherapy
- Risk of Dementia in Older Breast Cancer Survivors: A Population-Based Cohort Study of the Association with Adjuvant Chemotherapy
- Second malignancies after breast cancer: the impact of different treatment modalities
- Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates
- Sequence of Radiotherapy and Chemotherapy in Breast Cancer After Breast-Conserving Surgery
- Serum Molecular Signatures of Weight Change during Early Breast Cancer Chemotherapy
- Severe dietary restriction enhances cancer treatment: Protecting normal cells and sensitizing malignant cells to chemotherapy by fasting
- Significance of Histomorphology of Early Triple-Negative Breast Cancer
- Small node-negative (T1b-cN0) invasive hormone receptor-positive breast cancers: Is there a subpopulation that might have benefit from adjuvant chemotherapy?
- Symptom Management of Affective and Cognitive Disturbance With a Group of Cancer Survivors
- Synchronous Chemo-radiation Can Reduce Local Recurrence in Early Stage Breast Cancer: Results of the SECRAB Trial
- Synergistic Effects of Apigenin and Paclitaxel on Apoptosis of Cancer Cells
- Tamoxifen Alters the Plasma Concentration of Molecules Associated with Cardiovascular Risk in Women with Breast Cancer Undergoing Chemotherapy
- Targeting breast stem cells with the cancer preventive compounds curcumin and piperine
- The dark side of curcumin
- The direct efficiency of the different modes of scheme “paclitaxel + caelyx" in the treatment of the patients having inflammatory breast cancer
- The effects of exercise training on antitumor efficacy of doxorubicin in MDA-MB-231 breast cancer xenografts
- The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer
- The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials
- The extract of Prunus persica flesh (PPFE) attenuates chemotherapy-induced hepatotoxicity in mice
- The herbal medicine black cohosh increases the cytotoxicity of doxorubicin to breast cancer cells by inhibiting doxorubicin efflux
- The Longitudinal Relationship between Fatigue and Sleep in Breast Cancer Patients Undergoing Chemotherapy
- The prognostic impact of age in patients with triple-negative breast cancer
- The Role of Curcuma longa Against Doxorubicin (Adriamycin)-Induced Toxicity in Rats
- The role of neurogenesis in post-chemotherapy cognitive impairment
- Timing of re-excision surgery (S2) for positive margins (PM) and initiation of adjuvant systemic treatment (aRx) in early breast cancer patients (BC pts)
- Triple-Negative Breast Cancer: An Update on Neoadjuvant Clinical Trials
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- Vitamin D Deficiency Promotes Human Breast Cancer Growth in a Murine Model of Bone Metastasis
- Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol
- Weight change during adjuvant chemotherapy regimens for breast cancer
- Weight gain and recovery of pre-cancer weight after breast cancer treatments: evidence from the women’s healthy eating and living (WHEL) study